Premium
Nucleosome Assembly Alters the Accessibility of the Antitumor Agent Duocarmycin B 2 to Duplex DNA
Author(s) -
Zou Tingting,
Kizaki Seiichiro,
Pandian Ganesh N.,
Sugiyama Hiroshi
Publication year - 2016
Publication title -
chemistry – a european journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.687
H-Index - 242
eISSN - 1521-3765
pISSN - 0947-6539
DOI - 10.1002/chem.201600950
Subject(s) - nucleosome , linker dna , chemistry , dna , histone , linker , duplex (building) , alkylation , microbiology and biotechnology , biophysics , stereochemistry , combinatorial chemistry , biochemistry , biology , computer science , catalysis , operating system
To evaluate the reactivity of antitumor agents in a nucleosome architecture, we conducted in vitro studies to assess the alkylation level of duocarmycin B 2 on nucleosomes with core and linker DNA using sequencing gel electrophoresis. Our results suggested that the alkylating efficiencies of duocarmycin B 2 were significantly decreased in core DNA and increased at the histone‐free linker DNA sites when compared with naked DNA conditions. Our finding that nucleosome assembly alters the accessibility of duocarmycin B 2 to duplex DNA could advance its design as an antitumor agent.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom